top of page

NCI National Cancer Institute: Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research

  • Writer: Patient Education: Video
    Patient Education: Video
  • Jun 26, 2021
  • 1 min read

Updated: Apr 7, 2022

NCI National Cancer Institute: Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research

Immunotherapy CART Multiple Myeloma

Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy Research


An example of CART Cell therapy approved by FDA to treat relapsed & refractory Multiple Myeloma is





Posts Archive
bottom of page